Basic Information
| RNALocate ID: | RLID-D:11001528 |
| RNA Symbol: | hsa-miR-296-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-296-3p |
| RNA ID: | miRBase:MIMAT0004679 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002626 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002627 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11003872 | Exosome | HCC tissues | 30542726 |
| RLID:11003873 | Exosome | Plasma | 23663360 |
| RLID:11003874 | Exosome | Serum | 24683445 |
| RLID-D:11000655 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-296-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-34270 |
| MNDR | hsa-miR-296-3p | Lymphoma | MNDR-E-MI-34271 |
| MNDR | hsa-miR-296-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34272 |
| MNDR | hsa-miR-296-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34273 |
| MNDR | hsa-miR-296-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34274 |
| MNDR | hsa-miR-296-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34275 |
| MNDR | hsa-miR-296-3p | Her2-receptor positive breast cancer | MNDR-E-MI-34276 |
| MNDR | hsa-miR-296-3p | Gastric cancer | MNDR-E-MI-34277 |
| MNDR | hsa-miR-296-3p | Alzheimer disease | MNDR-E-MI-34278 |
| MNDR | hsa-miR-296-3p | Dysautonomia familial | MNDR-E-MI-34279 |
| MNDR | hsa-miR-296-3p | Lung cancer | MNDR-E-MI-34280 |
| MNDR | hsa-miR-296-3p | Parkinson disease | MNDR-E-MI-34281 |
| MNDR | hsa-miR-296-3p | Breast cancer | MNDR-E-MI-34282 |
| MNDR | hsa-miR-296-3p | Pancreatic cancer | MNDR-E-MI-34283 |
| MNDR | hsa-miR-296-3p | Colon cancer | MNDR-E-MI-34284 |
| MNDR | hsa-miR-296-3p | Colon adenocarcinoma | MNDR-E-MI-34285 |
| MNDR | hsa-miR-296-3p | Carcinoma ductal breast | MNDR-E-MI-34286 |
| MNDR | hsa-miR-296-3p | Glioblastoma | MNDR-E-MI-34287 |
| MNDR | hsa-miR-296-3p | Astrocytoma | MNDR-E-MI-34288 |
| MNDR | hsa-miR-296-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-34289 |
| MNDR | hsa-miR-296-3p | Liver cancer | MNDR-E-MI-34290 |
| MNDR | hsa-miR-296-3p | Lung squamous cell carcinoma | MNDR-E-MI-34291 |
| MNDR | hsa-miR-296-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-34292 |
| MNDR | hsa-miR-296-3p | Lung adenocarcinoma | MNDR-E-MI-34293 |
| MNDR | hsa-miR-296-3p | Thyroid carcinoma | MNDR-E-MI-34294 |
| MNDR | hsa-miR-296-3p | Ovarian carcinoma | MNDR-E-MI-34295 |
| MNDR | hsa-miR-296-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34296 |
| MNDR | hsa-miR-296-3p | Esophageal cancer | MNDR-E-MI-34297 |
| MNDR | hsa-miR-296-3p | Breast invasive carcinoma | MNDR-E-MI-34298 |
| MNDR | hsa-miR-296-3p | Hepatocellular carcinoma | MNDR-E-MI-34299 |
| MNDR | hsa-miR-296-3p | Skin cutaneous melanoma | MNDR-E-MI-34300 |
| MNDR | hsa-miR-296-3p | Skin melanoma | MNDR-E-MI-34301 |
| MNDR | hsa-miR-296-3p | Colorectal cancer | MNDR-E-MI-34302 |
| MNDR | hsa-miR-296-3p | Nasopharynx carcinoma | MNDR-E-MI-34303 |
| MNDR | hsa-miR-296-3p | Nasopharyngeal cancer | MNDR-E-MI-34304 |
| MNDR | hsa-miR-296-3p | Breast cancer her3+ negative | MNDR-E-MI-34305 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CX3CR1 | Homo sapiens | RR00381897 |
TOP